You have 9 free searches left this month | for more free features.

Condition

Advanced Solid Tumor (1)

Brain Metastases (1)

Breast Cancer (1)

Documented Her2 Overexpression (1)

HER2 Positive Breast Cancer (1)

Neurologically Stable (1)

Overall Status

Terminated (1)

Withdrawn (1)

Sign in for free

Phase

early phase 1 (1)

phase 2/phase 3 (1)

Sponsor

Merrimack Pharmaceuticals (1)

Pamela Munster (1)

Collaborator

Intervention

mm-302 (2)

trastuzumab (2)

capecitabine (1)

gemcitabine (1)

vinorelbine (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

mm-302

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Brain Metastases, Documented Her2 Overexpression, Advanced Solid Tumor Trial (MM-302, Trastuzumab)

Withdrawn

Brain Metastases
+3 more

MM-302
Trastuzumab

(no location specified)

May 2, 2017

Breast Cancer, HER2 Positive Breast Cancer Trial in Worldwide (MM-302, Gemcitabine, Capecitabine)

Terminated

Breast Cancer
HER2 Positive Breast Cancer

MM-302
+4 more

Glendale, Arizona
+108 more

Jan 4, 2017